KAYLA FRANK: Open Payments
NPI 1336828557 · FREMONT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $320 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $96 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Alkermes, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, AUSTEDO XR, FANAPT, CAPLYTA, TRINTELLIX, ARISTADA, REXULTI, INGREZZA.
Industry payments across OH — which companies pay providers there.
